Display Moresotrovimab looks really good - but not enough info about mortality.
Double-blind randomized study shows 85% reduction in hospitalisation.
Expected reduction in mortality but obviously with 292+292 patients there is as yet no evidence
https://www.medrxiv.org/conten…05.27.21257096v1.full.pdf
https://theconversation.com/wh…r-use-in-australia-165802
Still - this looks like the type of treatment that could really change COVID.
Small Negative - it is via IV infusion
https://www.forbes.com/sites/l…-compare/?sh=5e6ec7854b62
THH
They still have not tested for adverse effects with other drugs and it's recommended for obese and diabetics. Go figure